Literature DB >> 6157837

Antigenic and immunogenic characteristics of nuclear and membrane-associated simian virus 40 tumor antigen.

H R Soule, R E Lanford, J S Butel.   

Abstract

Antisera were prepared in syngeneic hosts against subcellular fractions of simian virus 40 (SV40)-transformed cells (MoalphaPM, MoalphaNuc), glutaraldehydefixed SV40-transformed cells (HaalphaH-50-G, MoalphaVLM-G), and electrophoretically purified denatured SV40 tumor antigen (T-ag) (RaalphaT). Immune sera were also collected from animals bearing tumors induced by SV40-transformed cells (HaalphaT, MoalphaT, HAF) and from SV40-immunized animals that had rejected a transplant of SV40-transformed cells (HaalphaS, MoalphaS). Immunological reagents prepared against cell surface (MoalphaPM, HaalphaS, MoalphaS, HaalphaH-50-G, MoalphaVLM-G) reacted exclusively with the surface of SV40-transformed cells by indirect immunofluorescence or protein A surface antigen radioimmunoassay. Immunological reagents prepared against the nuclear fraction (MoalphaNuc) or whole-cell determinants (HaalphaT, MoalphaT, HAF, RaalphaT) reacted with both the nuclei and surface of SV40-transformed or -infected cells. All reagents were capable of immunoprecipitating 96,000-molecular weight large T-ag from solubilized whole cell extracts of SV40-transformed cells. The exclusive surface reactivity of HaalphaS exhibited in immunofluorescence tests was abolished by solubilization of subcellular fractions, which then allowed immunoprecipitation of T-ag by HaalphaS from both nuclear and plasma membrane preparations. Specificity was established by the fact that all T-reactive reagents failed to react in serological tests against chemically transformed mouse cells, and sera from mice bearing transplants chemically transformed mouse cells (MoalphaDMBA-2) failed to react with SV40-transformed mouse or hamster cells. Reagents demonstrating positive surface immunofluorescence and protein A radioimmunoassay reactions against SV40-transformed cells were capable of blocking the surface binding of RaalphaT to SV40-transformed cells in a double-antibody surface antigen radioimmunoassay. This blocking ability demonstrated directly that a component specificity of each surface-reactive reagent is directed against SV40 T-ag. A model is presented which postulates that the differential detection of T-ag by the various serological reagents is a reflection of immunogenic and antigenic differences between T-ag polypeptides localized in nuclei and plasma membranes.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6157837      PMCID: PMC288614          DOI: 10.1128/JVI.33.2.887-901.1980

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Cellular and cell-free synthesis of simian virus 40 T-antigens in permissive and transformed cells.

Authors:  C Prives; Y Gluzman; E Winocour
Journal:  J Virol       Date:  1978-02       Impact factor: 5.103

2.  Organization and expression of early genes of simian virus 40.

Authors:  L V Crawford; C N Cole; A E Smith; E Paucha; P Tegtmeyer; K Rundell; P Berg
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

3.  Antiserum to polyacrylamide gel-purified simian virus 40 T antigen.

Authors:  R B Carroll; S M Goldfine; J A Melero
Journal:  Virology       Date:  1978-06-01       Impact factor: 3.616

4.  Complete nucleotide sequence of SV40 DNA.

Authors:  W Fiers; R Contreras; G Haegemann; R Rogiers; A Van de Voorde; H Van Heuverswyn; J Van Herreweghe; G Volckaert; M Ysebaert
Journal:  Nature       Date:  1978-05-11       Impact factor: 49.962

5.  Mutants of SV40 with an altered small t protein are reduced in their ability to transform cells.

Authors:  M J Sleigh; W C Topp; R Hanich; J F Sambrook
Journal:  Cell       Date:  1978-05       Impact factor: 41.582

6.  Transplantation immunity to simian virus 40-transformed cells in tumor-bearing mice. I. Development of cellular immunity to simian virus 40 tumor-specific transplantation antigens during tumorigenesis by transplanted cells.

Authors:  J M Zarling; S S Tevethia
Journal:  J Natl Cancer Inst       Date:  1973-01       Impact factor: 13.506

Review 7.  Oncogenicity and cell transformation by papovavirus SV40: the role of the viral genome.

Authors:  J S Butel; S S Tevethia; J L Melnick
Journal:  Adv Cancer Res       Date:  1972       Impact factor: 6.242

8.  Development in hamsters of antibodies against surface antigens present in cells transformed by papovavirus SV40.

Authors:  S S Tevethia; F Rapp
Journal:  J Immunol       Date:  1968-02       Impact factor: 5.422

9.  An immunochemical investigation of SV40 T antigens. 1. Production properties and specificity of rabbit antibody to purified simian virus 40 large-T antigen.

Authors:  D P Lane; A K Robbins
Journal:  Virology       Date:  1978-06-01       Impact factor: 3.616

10.  Studies on nondefective adenovirus-simian virus 40 hybrid viruses. I. A newly characterized simian virus 40 antigen induced by the Ad2+ND 1 virus.

Authors:  A M Lewis; W P Rowe
Journal:  J Virol       Date:  1971-02       Impact factor: 5.103

View more
  30 in total

1.  Idiotype network components are involved in the murine immune response to simian virus 40 large tumor antigen.

Authors:  R L Mernaugh; M H Shearer; R K Bright; R E Lanford; R C Kennedy
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

Review 2.  Possible role of anti-idiotypic antibodies in the induction of tumor immunity.

Authors:  R C Kennedy; E M Zhou; R E Lanford; T C Chanh; C A Bona
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

3.  Evidence for transmembrane orientation of acylated simian virus 40 large T antigen.

Authors:  U Klockmann; W Deppert
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

4.  Fine mapping two distinct antigenic sites on simian virus 40 (SV40) T antigen reactive with SV40-specific cytotoxic T-cell clones by using SV40 deletion mutants.

Authors:  R W Anderson; M J Tevethia; D Kalderon; A E Smith; S S Tevethia
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

5.  Association of simian virus 40 T antigen with the nuclear matrix of infected and transformed monkey cells.

Authors:  L Covey; Y Choi; C Prives
Journal:  Mol Cell Biol       Date:  1984-07       Impact factor: 4.272

6.  Comparison of the murine humoral immune response to recombinant simian virus 40 large tumor antigen: epitope specificity and idiotype expression.

Authors:  R K Bright; M H Shearer; R C Kennedy
Journal:  Cancer Immunol Immunother       Date:  1993-07       Impact factor: 6.968

7.  Simian virus 40 T-antigen-related cell surface antigen: serological demonstration on simian virus 40-transformed monolayer cells in situ.

Authors:  W Deppert; K Hanke; R Henning
Journal:  J Virol       Date:  1980-08       Impact factor: 5.103

8.  Abrogation of simian virus 40 DNA-mediated transformation of primary C57BL/6 mouse embryo fibroblasts by exposure to a simian virus 40-specific cytotoxic T-lymphocyte clone.

Authors:  H E Karjalainen; M J Tevethia; S S Tevethia
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

9.  Construction and characterization of viable deletion mutants of simian virus 40 lacking sequences near the 3' end of the early region.

Authors:  M Polvino-Bodnar; C N Cole
Journal:  J Virol       Date:  1982-08       Impact factor: 5.103

10.  Nonlytic simian virus 40-specific 100K phosphoprotein is associated with anchorage-independent growth in simian virus 40-transformed and revertant mouse cell lines.

Authors:  S Chen; M Verderame; A Lo; R Pollack
Journal:  Mol Cell Biol       Date:  1981-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.